ArticleCureus2024

Extensive-Disease Small-Cell Lung Cancer With Severe Immune-Related Adverse Events Due to Atezolizumab Maintaining a Complete Response for Two Years: A Case Report.

Sayaka Kudo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.